{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:28:51Z","timestamp":1790746131919,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"crossref","award":["No. 2021CXGC011101"],"award-info":[{"award-number":["No. 2021CXGC011101"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shandong Province,China","award":["ZR2020QH092"],"award-info":[{"award-number":["ZR2020QH092"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13695-9","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T02:20:59Z","timestamp":1753928459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["NSUN2-mediated RNA m5C modification drives multiple myeloma progression by enhancing the stability of HIP1 mRNA"],"prefix":"10.1038","volume":"15","author":[{"given":"Yang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saran","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3777-729X","authenticated-orcid":false,"given":"Congcong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"13695_CR1","doi-asserted-by":"publisher","unstructured":"Kumar, S. K. et al. Multiple myeloma. Nat. Reviews Disease Primers 3, 586. https:\/\/doi.org\/10.1038\/nrdp.2017.46 (2017).","DOI":"10.1038\/nrdp.2017.46"},{"key":"13695_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hon.2586","volume":"37","author":"SV Rajkumar","year":"2019","unstructured":"Rajkumar, S. V. Multiple myeloma: every year a new standard? Hematol. Oncol. 37, 62\u201365. https:\/\/doi.org\/10.1002\/hon.2586 (2019).","journal-title":"Hematol. Oncol."},{"key":"13695_CR3","doi-asserted-by":"publisher","unstructured":"Pinto, V. et al. Multiple myeloma: available therapies and causes of drug resistance. Cancers (Basel)  12, 526. https:\/\/doi.org\/10.3390\/cancers12020407 (2020).","DOI":"10.3390\/cancers12020407"},{"key":"13695_CR4","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1038\/bcj.2014.29","volume":"4","author":"K Dimopoulos","year":"2014","unstructured":"Dimopoulos, K., Gimsing, P. & Gr\u00f8nb\u00e6k, K. The role of epigenetics in the biology of multiple myeloma. Blood Cancer J. 4, e207. https:\/\/doi.org\/10.1038\/bcj.2014.29 (2014).","journal-title":"Blood Cancer J."},{"key":"13695_CR5","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1182\/blood-2014-10-567370","volume":"125","author":"J Corre","year":"2015","unstructured":"Corre, J., Munshi, N. & Avet-Loiseau, H. Genetics of multiple myeloma: another heterogeneity level? Blood 125, 1870\u20131876. https:\/\/doi.org\/10.1182\/blood-2014-10-567370 (2015).","journal-title":"Blood"},{"key":"13695_CR6","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00277-023-05283-6","volume":"102","author":"X Huang","year":"2023","unstructured":"Huang, X., Yang, Z., Li, Y. & Long, X. m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2. Ann. Hematol. 102, 1801\u20131810. https:\/\/doi.org\/10.1007\/s00277-023-05283-6 (2023).","journal-title":"Ann. Hematol."},{"key":"13695_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/bib\/bbx142","volume":"20","author":"X Chen","year":"2017","unstructured":"Chen, X. et al. RNA methylation and diseases: experimental results, databases, web servers and computational models. Brief. Bioinform. 20, 896\u2013917 (2017).","journal-title":"Brief. Bioinform."},{"key":"13695_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13045-018-0590-8","volume":"11","author":"Y Pan","year":"2018","unstructured":"Pan, Y., Ma, P., Liu, Y., Li, W. & Shu, Y. Multiple functions of m(6)A RNA methylation in cancer. J. Hematol. Oncol. 11, 48. https:\/\/doi.org\/10.1186\/s13045-018-0590-8 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"13695_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12943-020-01263-w","volume":"20","author":"P Nombela","year":"2021","unstructured":"Nombela, P., Miguel-L\u00f3pez, B. & Blanco, S. The role of m(6)A, m(5)C and \u03a8 RNA modifications in cancer: novel therapeutic opportunities. Mol. Cancer. 20, 18. https:\/\/doi.org\/10.1186\/s12943-020-01263-w (2021).","journal-title":"Mol. Cancer"},{"key":"13695_CR10","doi-asserted-by":"publisher","first-page":"767668","DOI":"10.3389\/fcell.2021.767668","volume":"9","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Role of main RNA methylation in hepatocellular carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine. Front. Cell. Dev. Biol. 9, 767668. https:\/\/doi.org\/10.3389\/fcell.2021.767668 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"13695_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41419-023-06036-z","volume":"14","author":"Y Jia","year":"2023","unstructured":"Jia, Y. et al. PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6. Cell. Death Dis. 14, 512. https:\/\/doi.org\/10.1038\/s41419-023-06036-z (2023).","journal-title":"Cell. Death Dis."},{"key":"13695_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.ymthe.2021.12.012","volume":"30","author":"A Xu","year":"2022","unstructured":"Xu, A. et al. FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m(6)A-YTHDF2-dependent manner. Mol. Ther. 30, 1104\u20131118. https:\/\/doi.org\/10.1016\/j.ymthe.2021.12.012 (2022).","journal-title":"Mol. Ther."},{"key":"13695_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12967-022-03750-8","volume":"20","author":"C Jia","year":"2022","unstructured":"Jia, C. et al. HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma. J. Transl Med. 20, 537. https:\/\/doi.org\/10.1186\/s12967-022-03750-8 (2022).","journal-title":"J. Transl Med."},{"key":"13695_CR14","doi-asserted-by":"publisher","first-page":"e1510","DOI":"10.1002\/wrna.1510","volume":"10","author":"L Trixl","year":"2019","unstructured":"Trixl, L. & Lusser, A. The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark. Wiley Interdiscip Rev. RNA. 10, e1510. https:\/\/doi.org\/10.1002\/wrna.1510 (2019).","journal-title":"Wiley Interdiscip Rev. RNA"},{"key":"13695_CR15","doi-asserted-by":"publisher","unstructured":"Heissenberger, C. et al. The ribosomal RNA m(5)C methyltransferase NSUN-1 modulates healthspan and oogenesis in caenorhabditis elegans. Elife 9, 856. https:\/\/doi.org\/10.7554\/eLife.56205 (2020).","DOI":"10.7554\/eLife.56205"},{"key":"13695_CR16","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.7150\/ijbs.61439","volume":"17","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. The role of RNA m(5)C modification in cancer metastasis. Int. J. Biol. Sci. 17, 3369\u20133380. https:\/\/doi.org\/10.7150\/ijbs.61439 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"13695_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature25434","volume":"554","author":"Q Shen","year":"2018","unstructured":"Shen, Q. et al. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation. Nature 554, 123\u2013127. https:\/\/doi.org\/10.1038\/nature25434 (2018).","journal-title":"Nature"},{"key":"13695_CR18","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/cr.2017.55","volume":"27","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m(5)C reader. Cell. Res. 27, 606\u2013625. https:\/\/doi.org\/10.1038\/cr.2017.55 (2017).","journal-title":"Cell. Res."},{"key":"13695_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2014.06.006","volume":"31","author":"S Blanco","year":"2014","unstructured":"Blanco, S. & Frye, M. Role of RNA methyltransferases in tissue renewal and pathology. Curr. Opin. Cell. Biol. 31, 1\u20137. https:\/\/doi.org\/10.1016\/j.ceb.2014.06.006 (2014).","journal-title":"Curr. Opin. Cell. Biol."},{"key":"13695_CR20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ncomms1692","volume":"3","author":"X Zhang","year":"2012","unstructured":"Zhang, X. et al. The tRNA methyltransferase NSun2 stabilizes p16INK\u2074 mRNA by methylating the 3\u2019-untranslated region of p16. Nat. Commun. 3, 712. https:\/\/doi.org\/10.1038\/ncomms1692 (2012).","journal-title":"Nat. Commun."},{"key":"13695_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat. Cell Biol. 21, 978\u2013990. https:\/\/doi.org\/10.1038\/s41556-019-0361-y (2019).","journal-title":"Nat. Cell Biol."},{"key":"13695_CR22","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/wrna.1380","volume":"7","author":"W Wang","year":"2016","unstructured":"Wang, W. mRNA methylation by NSUN2 in cell proliferation. WIREs RNA. 7, 838\u2013842. https:\/\/doi.org\/10.1002\/wrna.1380 (2016).","journal-title":"WIREs RNA"},{"key":"13695_CR23","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1002\/jcb.25957","volume":"118","author":"Q Li","year":"2017","unstructured":"Li, Q. et al. NSUN2-Mediated m5C methylation and METTL3\/METTL14-Mediated m6A methylation cooperatively enhance p21 translation. J. Cell. Biochem. 118, 2587\u20132598. https:\/\/doi.org\/10.1002\/jcb.25957 (2017).","journal-title":"J. Cell. Biochem."},{"key":"13695_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-022-03427-2","volume":"20","author":"M Li","year":"2022","unstructured":"Li, M. et al. 5-methylcytosine RNA methyltransferases and their potential roles in cancer. J. Transl Med. 20, 214. https:\/\/doi.org\/10.1186\/s12967-022-03427-2 (2022).","journal-title":"J. Transl Med."},{"key":"13695_CR25","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.1038\/s41388-020-01475-w","volume":"39","author":"Z Sun","year":"2020","unstructured":"Sun, Z. et al. Aberrant NSUN2-mediated m(5)C modification of H19 LncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene 39, 6906\u20136919. https:\/\/doi.org\/10.1038\/s41388-020-01475-w (2020).","journal-title":"Oncogene"},{"key":"13695_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41419-023-05646-x","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang, M. et al. NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m(5)C methylation. Cell. Death Dis. 14, 125. https:\/\/doi.org\/10.1038\/s41419-023-05646-x (2023).","journal-title":"Cell. Death Dis."},{"key":"13695_CR27","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1038\/s41388-022-02325-7","volume":"41","author":"SY Chen","year":"2022","unstructured":"Chen, S. Y. et al. RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer. Oncogene 41, 3162\u20133176. https:\/\/doi.org\/10.1038\/s41388-022-02325-7 (2022).","journal-title":"Oncogene"},{"key":"13695_CR28","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/jco.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo, A. et al. Revised international staging system for multiple myeloma: a report from international myeloma working group. J. Clin. Oncol. 33, 2863\u20132869. https:\/\/doi.org\/10.1200\/jco.2015.61.2267 (2015).","journal-title":"J. Clin. Oncol."},{"key":"13695_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.semcancer.2017.09.007","volume":"51","author":"M Alzrigat","year":"2018","unstructured":"Alzrigat, M., P\u00e1rraga, A. A. & Jernberg-Wiklund, H. Epigenetics in multiple myeloma: from mechanisms to therapy. Sem. Cancer Biol. 51, 101\u2013115. https:\/\/doi.org\/10.1016\/j.semcancer.2017.09.007 (2018). https:\/\/doi:.","journal-title":"Sem. Cancer Biol."},{"key":"13695_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.gde.2015.03.008","volume":"30","author":"R Szalat","year":"2015","unstructured":"Szalat, R. & Munshi, N. C. Genomic heterogeneity in multiple myeloma. Curr. Opin. Genet. Dev. 30, 56\u201365. https:\/\/doi.org\/10.1016\/j.gde.2015.03.008 (2015).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"13695_CR31","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/s42003-024-06918-8","volume":"7","author":"M Yu","year":"2024","unstructured":"Yu, M. et al. Aberrant NSUN2-mediated m5C modification of Exosomal LncRNA MALAT1 induced RANKL-mediated bone destruction in multiple myeloma. Commun. Biology. 7, 1249. https:\/\/doi.org\/10.1038\/s42003-024-06918-8 (2024).","journal-title":"Commun. Biology"},{"key":"13695_CR32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41419-021-04127-3","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. NSUN2 modified by SUMO-2\/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell. Death Dis. 12, 842. https:\/\/doi.org\/10.1038\/s41419-021-04127-3 (2021).","journal-title":"Cell. Death Dis."},{"key":"13695_CR33","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1038\/s41388-021-01978-0","volume":"40","author":"J Su","year":"2021","unstructured":"Su, J. et al. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization. Oncogene 40, 5814\u20135828. https:\/\/doi.org\/10.1038\/s41388-021-01978-0 (2021).","journal-title":"Oncogene"},{"key":"13695_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.7150\/ijbs.79205","volume":"19","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Upregulation of LRRC8A by m(5)C modification-mediated mRNA stability suppresses apoptosis and facilitates tumorigenesis in cervical cancer. Int. J. Biol. Sci. 19, 691\u2013704. https:\/\/doi.org\/10.7150\/ijbs.79205 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"13695_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41420-023-01521-y","volume":"9","author":"G Zhang","year":"2023","unstructured":"Zhang, G. et al. NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer. Cell. Death Discov. 9, 219. https:\/\/doi.org\/10.1038\/s41420-023-01521-y (2023).","journal-title":"Cell. Death Discov"},{"key":"13695_CR36","doi-asserted-by":"publisher","first-page":"BSR20222150","DOI":"10.1042\/BSR20222150","volume":"43","author":"L K\u00fcster","year":"2023","unstructured":"K\u00fcster, L. et al. The actin bundling activity of ITPKA mainly accounts for its migration-promoting effect in lung cancer cells. Biosci. Rep. 43, BSR20222150. https:\/\/doi.org\/10.1042\/BSR20222150 (2023).","journal-title":"Biosci. Rep."},{"key":"13695_CR37","doi-asserted-by":"publisher","unstructured":"Luo, X. et al. ITPKA phosphorylates PYCR1 and promotes the progression of glioma. Heliyon 10, 856. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35303 (2024).","DOI":"10.1016\/j.heliyon.2024.e35303"},{"key":"13695_CR38","doi-asserted-by":"publisher","unstructured":"Chen, Y. S., Yang, W. L., Zhao, Y. L. & Yang, Y. G. Dynamic transcriptomic m5C and its regulatory role in RNA processing. WIREs RNA. 12, 562. https:\/\/doi.org\/10.1002\/wrna.1639 (2021).","DOI":"10.1002\/wrna.1639"},{"key":"13695_CR39","doi-asserted-by":"publisher","first-page":"e1273","DOI":"10.1002\/ctm2.1273","volume":"13","author":"S Zuo","year":"2023","unstructured":"Zuo, S. et al. NSUN2-mediated m(5) C RNA methylation dictates retinoblastoma progression through promoting PFAS mRNA stability and expression. Clin. Transl Med. 13, e1273. https:\/\/doi.org\/10.1002\/ctm2.1273 (2023).","journal-title":"Clin. Transl Med."},{"key":"13695_CR40","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1158\/0008-5472.CAN-06-4803","volume":"67","author":"SV Bradley","year":"2007","unstructured":"Bradley, S. V. et al. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor. Cancer Res. 67, 3609\u20133615. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4803 (2007).","journal-title":"Cancer Res."},{"key":"13695_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1172\/jci15529","volume":"110","author":"DS Rao","year":"2002","unstructured":"Rao, D. S. et al. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. J. Clin. Invest. 110, 351\u2013360. https:\/\/doi.org\/10.1172\/jci15529 (2002).","journal-title":"J. Clin. Invest."},{"key":"13695_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S1535-6108(03)00107-7","volume":"3","author":"DS Rao","year":"2003","unstructured":"Rao, D. S. et al. Altered receptor trafficking in Huntingtin interacting protein 1-transformed cells. Cancer Cell. 3, 471\u2013482. https:\/\/doi.org\/10.1016\/S1535-6108(03)00107-7 (2003).","journal-title":"Cancer Cell."},{"key":"13695_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3892\/ol.2020.12340","volume":"21","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Abnormally high HIP1 expression is associated with metastatic behaviors and poor prognosis in ESCC. Oncol. Lett. 21, 79. https:\/\/doi.org\/10.3892\/ol.2020.12340 (2021).","journal-title":"Oncol. Lett."},{"key":"13695_CR44","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1158\/0008-5472.CAN-04-4658","volume":"65","author":"SV Bradley","year":"2005","unstructured":"Bradley, S. V. et al. Serum antibodies to Huntingtin interacting Protein-1: a new blood test for prostate cancer. Cancer Res. 65, 4126\u20134133. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4658 (2005).","journal-title":"Cancer Res."},{"key":"13695_CR45","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/ijd.12454","volume":"54","author":"S Marghalani","year":"2015","unstructured":"Marghalani, S., Feller, J. K., Mahalingam, M. & Mirzabeigi, M. Huntingtin interacting protein 1 as a histopathologic adjunct in the diagnosis of Merkel cell carcinoma. Int. J. Dermatol. 54, 640\u2013647. https:\/\/doi.org\/10.1111\/ijd.12454 (2015).","journal-title":"Int. J. Dermatol."},{"key":"13695_CR46","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1182\/blood.V91.12.4419","volume":"91","author":"TS Ross","year":"1998","unstructured":"Ross, T. S., Bernard, O. A., Berger, R. & Gilliland, D. G. Fusion of Huntingtin interacting protein 1 to Platelet-Derived growth factor \u03b2 receptor (PDGF\u03b2R) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood 91, 4419\u20134426. https:\/\/doi.org\/10.1182\/blood.V91.12.4419 (1998).","journal-title":"Blood"},{"key":"13695_CR47","doi-asserted-by":"publisher","first-page":"8923","DOI":"10.1158\/0008-5472.CAN-07-2153","volume":"67","author":"SV Bradley","year":"2007","unstructured":"Bradley, S. V. et al. Aberrant Huntingtin interacting protein 1 in lymphoid malignancies. Cancer Res. 67, 8923\u20138931. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-2153 (2007).","journal-title":"Cancer Res."},{"key":"13695_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.semcancer.2024.08.002","volume":"106\u2013107","author":"V Penugurti","year":"2024","unstructured":"Penugurti, V., Manne, R. K., Bai, L., Kant, R. & Lin, H. K. AMPK: the energy sensor at the crossroads of aging and cancer. Sem. Cancer Biol. 106\u2013107, 15\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2024.08.002 (2024).","journal-title":"Sem. Cancer Biol."},{"key":"13695_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2021.04.006","volume":"85","author":"CC Hsu","year":"2022","unstructured":"Hsu, C. C., Peng, D., Cai, Z. & Lin, H. K. AMPK signaling and its targeting in cancer progression and treatment. Semin Cancer Biol. 85, 52\u201368. https:\/\/doi.org\/10.1016\/j.semcancer.2021.04.006 (2022).","journal-title":"Semin Cancer Biol."},{"key":"13695_CR50","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.2147\/ott.S193787","volume":"12","author":"H Ouyang","year":"2019","unstructured":"Ouyang, H., Zhou, E. & Wang, H. Mst1-Hippo pathway triggers breast cancer apoptosis via inducing mitochondrial fragmentation in a manner dependent on JNK-Drp1 axis. Onco Targets Ther. 12, 1147\u20131159. https:\/\/doi.org\/10.2147\/ott.S193787 (2019).","journal-title":"Onco Targets Ther."},{"key":"13695_CR51","first-page":"23","volume":"17","author":"H Ruppin","year":"1984","unstructured":"Ruppin, H. [Motility inhibitors and secretion inhibitors]. Schweiz. Med. Wochenschr Suppl. 17, 23\u201328 (1984).","journal-title":"Schweiz. Med. Wochenschr Suppl."},{"key":"13695_CR52","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3892\/ijmm.2018.3857","volume":"42","author":"H Mei","year":"2018","unstructured":"Mei, H. et al. Pterostilbene inhibits nutrient metabolism and induces apoptosis through AMPK activation in multiple myeloma cells. Int. J. Mol. Med. 42, 2676\u20132688. https:\/\/doi.org\/10.3892\/ijmm.2018.3857 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"13695_CR53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.coph.2012.01.016","volume":"12","author":"A Banerjee","year":"2012","unstructured":"Banerjee, A., Koziol-White, C. & Panettieri, R. Jr. p38 MAPK inhibitors, IKK2 inhibitors, and TNF\u03b1 inhibitors in COPD. Curr. Opin. Pharmacol. 12, 287\u2013292. https:\/\/doi.org\/10.1016\/j.coph.2012.01.016 (2012).","journal-title":"Curr. Opin. Pharmacol."},{"key":"13695_CR54","doi-asserted-by":"publisher","first-page":"116738","DOI":"10.1016\/j.biopha.2024.116738","volume":"175","author":"X Li","year":"2024","unstructured":"Li, X. et al. Matrine induces autophagic cell death by triggering ros\/ampk\/mtor axis and apoptosis in multiple myeloma. Biomed. Pharmacother. 175, 116738. https:\/\/doi.org\/10.1016\/j.biopha.2024.116738 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"13695_CR55","doi-asserted-by":"publisher","first-page":"153556","DOI":"10.1016\/j.tox.2023.153556","volume":"493","author":"Z Liu","year":"2023","unstructured":"Liu, Z., Wang, N., Meng, Z., Lu, S. & Peng, G. Pseudolaric acid B triggers cell apoptosis by activating AMPK\/JNK\/DRP1\/mitochondrial fission pathway in hepatocellular carcinoma. Toxicology 493, 153556. https:\/\/doi.org\/10.1016\/j.tox.2023.153556 (2023).","journal-title":"Toxicology"},{"key":"13695_CR56","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013d677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"13695_CR57","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"13695_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13695-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13695-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13695-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:19:17Z","timestamp":1757319557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13695-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13695"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13695-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Ethics Committee of the Second Hospital of Shandong University approved this study (KYLL-2019(KJ)P-0125) in line with the Declaration of Helsinki. The Ethics Committee of the Second Hospital of Shandong University approved the animal experiments (No. KYLL-2019(KJ)A-0181).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"27888"}}